Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
featured
  • 45 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.

This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.  

schizophrenia disorders
antipsychotics
  • 22 views
  • 22 Dec, 2020
  • 1 location
featured
Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia

Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia

  • 220 views
  • 23 Nov, 2020
  • 1 location
featured
Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment

Study to Evaluate an Investigational Drug in Patients With Schizophrenia on Stable Antipsychotic Treatment

  • 244 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotic Medications (GRATITUDE)

Corcept is conducting this study to determine whether the investigational study drug miricorilant is safe and effective in reducing the weight gain in obese participants taking antipsychotic medications. Miricorilant is currently being tested for its use in reducing the weight gain due to antipsychoticdrugs but not been approved in any …

  • 0 views
  • 06 Apr, 2021
  • 1 location
Pharmacogenetic Supported Prescribing in Kids

Implementation of pharmacogenetic testing for children and adolescents aged 7-17 who are starting or changing psychiatric medication.

  • 0 views
  • 23 Mar, 2021
  • 1 location
a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

This study is a pilot phased interventional clinical trial . The first stage will recruit 10 patients with antipsychotic induced extrapyramidal symptoms.The patients will take pramipexole for 8 weeks. The inital dose of pramipexole will be 0.375 mg/d, and the adjustment of drug dose will be depended on the the …

  • 0 views
  • 23 Jan, 2021
  • 1 location
R33: Levetiracetam in Early Psychosis

This is a 12 week study of Levetiracetam in conjunction with a second generation antipsychotic in medication-free first episode psychosis participants. Treatment with antipsychotics has been

  • 0 views
  • 26 Jan, 2021
  • 1 location
Tolerability Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

syndrome), currently treated with atypical antipsychotics. Patient Population: The intention is to treat 45 patients diagnosed with schizophrenia, who are currently suffering mainly from

antipsychotics
cognitive deficits
  • 0 views
  • 07 Nov, 2020
  • 1 location
The Effect of Guanfacine on Delirium in Critically Ill Patients

cost, increased ventilator days, and long-term cognitive disability. Various pharmacologic agents including dopamine antagonists, acetylcholinesterase inhibitors, melatonin, antipsychotics, alpha-2

  • 0 views
  • 26 Jan, 2021
  • 1 location